(Q38050877)

27 August 2017

Monitoring of therapy for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

27 August 2017

0 references

author name string

Emanuel Burri

series ordinal

1

1 reference

27 August 2017

Christoph Beglinger

series ordinal

2

1 reference

27 August 2017

Frank Serge Lehmann

series ordinal

3

1 reference

27 August 2017

5 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

86 Suppl 1

1 reference

27 August 2017

1-5

1 reference

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

27 August 2017

1 reference

Clinical implications of mucosal healing for the management of IBD.

21 January 2018

1 reference

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

21 January 2018

1 reference

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis

21 January 2018

1 reference

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

21 January 2018

1 reference

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

21 January 2018

1 reference

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

21 January 2018

1 reference

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.

21 January 2018

1 reference

Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

21 January 2018

1 reference

Predicting outcome in severe ulcerative colitis

21 January 2018

1 reference

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

21 January 2018

1 reference

Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.

21 January 2018

1 reference

Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis.

21 January 2018

1 reference

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

21 January 2018

1 reference

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

21 January 2018

1 reference

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

21 January 2018

1 reference

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341953

1 reference

release_gbx3ftbxofg6rjh4sywcbcauje

27 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gbx3ftbxofg6rjh4sywcbcauje

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference